# Novo Nordisk a S: Form 6-K, filed Apr 7, 2026

- Company: [Novo Nordisk a S](/companies/nvo.md) (CIK 353278)
- Form: 6-K
- Filed: 2026-04-07
- Accepted by EDGAR: Apr 7, 2026, 07:28 ET
- Period: 2026-04-07
- Accession: 0001171843-26-002279
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/353278/000117184326002279/f6k_040726.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/353278/000117184326002279/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/353278/000117184326002279/f6k_040726.htm

Filed Apr 7, 2026.
Source: SEC EDGAR, the filing index for accession 0001171843-26-002279. Last ingested by Listed: Nov 9, 2026, 17:51 ET. No prices; not investment advice.